Anamaria A. Camargo lab

Human tumors are driven by genomic alterations that disrupt key oncogenic pathways. Building on nearly 40 years of research, the characterization of these genomic alterations is now being used to improve cancer diagnosis and treatment. Our group at the Molecular Oncology Center of the Hospital Sírio-Libanês is developing strategies to incorporate comprehensive tumor genomic profiling into the routine care of cancer patients, improving diagnosis and facilitating rational treatment choices.